NCT03607396View on ClinicalTrials.gov

Study for Evaluating the Real Use of Inhaled Aztreonam Lysine in Patients With Cystic Fibrosis

UnknownOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions
Cystic Fibrosis
Trial Locations (3)

08035

RECRUITING

Hospital Vall d'Hebron, Barcelona

Unknown

NOT_YET_RECRUITING

Hospital La Fe, Valencia

RECRUITING

Hospital 12 de Octubre, Madrid

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT03607396 - Study for Evaluating the Real Use of Inhaled Aztreonam Lysine in Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter